Daiichi Sankyo Co Ltd – Strategy, SWOT and Corporate Finance Report

Daiichi Sankyo Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company which carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompasses medicines for cardiovascular, neurological, nephrologic, diabetic, metabolic and infectious diseases; and various types of cancers. Daiichi Sankyo sells its products through its group companies, and an extensive network of medical representatives. It has operations in North America, South and Central America, Europe and Asia. Daiichi Sankyo is headquartered in Tokyo, Japan.

Scope

Detailed information on Daiichi Sankyo Co Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Daiichi Sankyo Co Ltd in the form of a SWOT analysis

An in-depth view of the business model of Daiichi Sankyo Co Ltd including a breakdown and examination of key business segments

News about Daiichi Sankyo Co Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Daiichi Sankyo Co Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Daiichi Sankyo Co Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Daiichi Sankyo Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Astellas Pharma Inc

Taisho Pharmaceutical Holdings Co Ltd

Sumitomo Dainippon Pharma Co Ltd

Shionogi & Co Ltd

Otsuka Pharmaceutical Co Ltd

Merck & Co Inc

Chugai Pharmaceutical Co Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Daiichi Sankyo Co Ltd - Key Facts

Daiichi Sankyo Co Ltd - Key Employees

Daiichi Sankyo Co Ltd - Key Employee Biographies

Daiichi Sankyo Co Ltd - Major Products and Services

Daiichi Sankyo Co Ltd - History

Daiichi Sankyo Co Ltd - Company Statement

Daiichi Sankyo Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

Daiichi Sankyo Co Ltd - Business Description

Business Segment: Healthcare (OTC) Products

Overview

Performance

Business Segment: Others

Performance

Business Segment: Prescription Drugs

Overview

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: North America

Performance

Geographical Segment: Other Regions

Performance

R&D Overview

Daiichi Sankyo Co Ltd - Corporate Strategy

Daiichi Sankyo Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Daiichi Sankyo Co Ltd - Strengths

Daiichi Sankyo Co Ltd - Weaknesses

Daiichi Sankyo Co Ltd - Opportunities

Daiichi Sankyo Co Ltd - Threats

Daiichi Sankyo Co Ltd - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Daiichi Sankyo Co Ltd, Recent Deals Summary

Section 5 Company’s Recent Developments

May 28, 2019: Integral Molecular reaches milestone in immuno-oncology target discovery collaboration with Daiichi Sankyo

May 17, 2019: Daiichi Sankyo announces update to H5N1 influenza vaccine national project

May 10, 2019: Daiichi Sankyo announces changes to members of the Board and members of the Audit and Supervisory Board

Apr 26, 2019: Daiichi sankyo announcement regarding vaccine quality testing methods

Mar 29, 2019: AstraZeneca and Daiichi Sankyo sign $6.9bn cancer drug development deal

Mar 29, 2019: Daiichi Sankyo announces chief executive officer (CEO) change

Feb 22, 2019: Daiichi Sankyo appoints new group corporate officers

Feb 22, 2019: Daiichi Sankyo announces organizational restructuring effective April 1, 2019 in Japan

Feb 22, 2019: Daiichi Sankyo shifts several top leaders to new roles for Company's launch into its next growth phase

Jan 31, 2019: Daiichi Sankyo Announces Transfer of Daiichi Sankyo Propharma Takatsuki Plant and Company Split (Simple Absorption-type Company Split)

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Daiichi Sankyo Co Ltd, Key Facts

Daiichi Sankyo Co Ltd, Key Employees

Daiichi Sankyo Co Ltd, Key Employee Biographies

Daiichi Sankyo Co Ltd, Major Products and Services

Daiichi Sankyo Co Ltd, History

Daiichi Sankyo Co Ltd, Subsidiaries

Daiichi Sankyo Co Ltd, Joint Venture

Daiichi Sankyo Co Ltd, Key Competitors

Daiichi Sankyo Co Ltd, Ratios based on current share price

Daiichi Sankyo Co Ltd, Annual Ratios

Daiichi Sankyo Co Ltd, Annual Ratios (Cont…1)

Daiichi Sankyo Co Ltd, Annual Ratios (Cont…2)

Daiichi Sankyo Co Ltd, Interim Ratios

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Daiichi Sankyo Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Daiichi Sankyo Co Ltd, Performance Chart (2015 – 2019)

Daiichi Sankyo Co Ltd, Ratio Charts

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports